Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	3.33	77.18	74.69
Graham Fair Price	-0.78	4.31	4.35
PEG	-1487.59	-14.21	-0.89
Price/Book	8.65	29.51	27.16
Price/Cash Flow	-40.30	97.63	163.54
Prices/Earnings	10.88	31.57	28.48
Price/Sales	7.99	8.10	7.50
Price/FCF	-40.30	97.63	163.54
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-1.63	0.43	0.44
Operating Margin	10.94	0.11	0.10
ROA	-1.73	0.02	0.02
ROE	0.24	0.23	-2.01
ROIC	0.03	0.03	-2.67
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-24.68
Dividends QOQ	< 0.005	0.31	5166.59
EBIT QOQ	-0.39	0.13	-67.10
EPS QOQ	-0.32	-0.02	93.02
FCF QOQ	-0.71	0.84	17.28
Revenue QOQ	-0.08	0.02	-80.66
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	66.11	65.11	-1.51
Days Sales Outstanding (DSO)	33.17	36.59	10.32
Inventory Turnover	1.36	1.38	1.54
Debt/Capitalization	0.89	0.89	0.22
Quick Ratio	0.56	0.60	7.85
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.88	1.88	0.23
Cash	0.43	0.53	22.57
Capex	-0.19	-0.18	2.60
Free Cash Flow	0.31	0.57	82.42
Revenue	6.79	6.85	0.85
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.20	1.21	0.76
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.91	19.06	-4.25
Naive Interpretation	Member

06 - Financial Health · Weak

Rating